Pneumococcal Vaccines: US CDC Panel Supports Universal Use In Adults Down To Age 50

ACIP is shifting to an age-based recommendation for vaccination in people as young as 50 years old. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Product Reviews